NRX Pharmaceuticals (NRXP)

NRX Pharmaceuticals (NRXP) Balance Sheet


NRX Pharmaceuticals Balance Sheet

NRX Pharmaceuticals's total assets for Q4 2023 were $3.79M, a decrease of -48.22% from the previous quarter. NRXP total liabilities were $18.86M for the fiscal quarter, a -1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 7.32M$ 25.82M$ 32.73M$ 2.94M
Total Liabilities
$ 19.05M$ 18.41M$ 11.92M$ 46.71M
Total Equity Gross Minority
$ -11.73M$ 7.41M$ 20.81M$ -43.77M
Total Capitalization
$ -713.00K$ 7.41M$ 20.81M$ -43.22M
Preferred Stock Equity
Capital Lease Obligations
Currency in USD

NRX Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis